AU2002349268A1 - Medicine for preventing and treating bromidrosis - Google Patents

Medicine for preventing and treating bromidrosis

Info

Publication number
AU2002349268A1
AU2002349268A1 AU2002349268A AU2002349268A AU2002349268A1 AU 2002349268 A1 AU2002349268 A1 AU 2002349268A1 AU 2002349268 A AU2002349268 A AU 2002349268A AU 2002349268 A AU2002349268 A AU 2002349268A AU 2002349268 A1 AU2002349268 A1 AU 2002349268A1
Authority
AU
Australia
Prior art keywords
medicine
preventing
bromidrosis
treating
treating bromidrosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002349268A
Other versions
AU2002349268B2 (en
Inventor
Marc Heckmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10146647A external-priority patent/DE10146647A1/en
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of AU2002349268A1 publication Critical patent/AU2002349268A1/en
Assigned to ALLERGAN, INC. reassignment ALLERGAN, INC. Request for Assignment Assignors: HECKMANN, MARC
Application granted granted Critical
Publication of AU2002349268B2 publication Critical patent/AU2002349268B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002349268A 2001-09-21 2002-09-23 Medicine for preventing and treating bromidrosis Ceased AU2002349268B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10146647.1 2001-09-21
DE10146647A DE10146647A1 (en) 2001-09-21 2001-09-21 Medicines for the prophylaxis and therapy of bromhidrosis
PCT/DE2002/003561 WO2003026602A2 (en) 2001-09-21 2002-09-23 Medicine for preventing and treating bromidrosis

Publications (2)

Publication Number Publication Date
AU2002349268A1 true AU2002349268A1 (en) 2003-06-26
AU2002349268B2 AU2002349268B2 (en) 2007-12-13

Family

ID=7699852

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002349268A Ceased AU2002349268B2 (en) 2001-09-21 2002-09-23 Medicine for preventing and treating bromidrosis

Country Status (16)

Country Link
US (1) US20050036966A1 (en)
EP (2) EP1427385B1 (en)
JP (1) JP4966478B2 (en)
KR (1) KR100796243B1 (en)
CN (1) CN1289061C (en)
AU (1) AU2002349268B2 (en)
CA (1) CA2461117C (en)
DE (1) DE10146647A1 (en)
EA (2) EA011988B1 (en)
HU (1) HU230398B1 (en)
IL (2) IL160875A0 (en)
MX (1) MXPA04002614A (en)
PL (1) PL209639B1 (en)
UA (1) UA78718C2 (en)
WO (1) WO2003026602A2 (en)
ZA (1) ZA200402123B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030113349A1 (en) 2001-12-18 2003-06-19 Coleman William P. Topically applied clostridium botulinum toxin compositions and treatment methods
US7288259B2 (en) 2002-08-19 2007-10-30 Ira Sanders Treatment of holocrine gland dysfunction with clostridia neurotoxins
EP1599219A1 (en) * 2003-03-06 2005-11-30 Botulinum Toxin Research Associates, Inc. Treatment of chronic chalazion and hordeolum with botulinum toxin
US8048423B2 (en) * 2003-12-09 2011-11-01 Allergan, Inc. Botulinum toxin therapy for skin disorders
BRPI0608249A2 (en) * 2005-03-03 2009-12-08 Revance Therapeutics Inc formulation, method for topical application and kit for transdermal botulinum toxin delivery
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
CA2671447A1 (en) 2006-12-01 2008-06-12 Anterios, Inc. Amphiphilic entity nanoparticles
BRPI0914630A2 (en) * 2008-06-26 2019-09-24 Anterios Inc dermal release
US8454975B1 (en) * 2010-01-11 2013-06-04 Elizabeth VanderVeer Method for enhancing skin appearance
EP3541358A1 (en) 2016-11-21 2019-09-25 Eirion Therapeutics, Inc. Transdermal delivery of large agents
US11191819B2 (en) 2018-08-28 2021-12-07 Ira Sanders Skin therapeutics

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19852981A1 (en) * 1998-11-17 2000-05-18 Martin Schmidt Use of botulinum toxin and its derivatives in topical treatment compositions to influence acetylcholine-dependent body functions
US20020086036A1 (en) * 2000-12-05 2002-07-04 Allergan Sales, Inc. Methods for treating hyperhidrosis
US20030113349A1 (en) * 2001-12-18 2003-06-19 Coleman William P. Topically applied clostridium botulinum toxin compositions and treatment methods

Similar Documents

Publication Publication Date Title
AU2002219472A1 (en) Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens
AU2002254158A1 (en) Medical devices, compositions and methods for treating vulnerable plaque
AU2002326600A1 (en) Side-exit catheter and method for its use
AU2002342613A1 (en) Treatment for wounds
AU2002243023A1 (en) Compositions for preventing and/or treating oral diseases
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
AUPR839001A0 (en) Dosage form, device and methods of treatment
AU2001256373A1 (en) Syringe and method for the use thereof
AU2002349268A1 (en) Medicine for preventing and treating bromidrosis
HUP0401913A3 (en) Medicine for preventing and treating bromhidrosis
AU2002319286A1 (en) Skin treatment
AUPQ232599A0 (en) Drug for treating fractures
AU2002335667A1 (en) Modified reoviral therapy
AU2002337713A1 (en) Pharmaceutical compositions and methods for treating cancer
AU2002352925A1 (en) Method for treating and preventing pancreatitis
AU2002305138A1 (en) Methods and materials for cancer treatment
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
AU2002342188A1 (en) Methods and compositions for treating flavivirus-mediated disease
AU2002353907A1 (en) Methods for treating wounds using melanin and related substances
AU2001268762A1 (en) Treatment and therapy apparatus
AU2002353915A1 (en) Methods and compositions for treating rotavirus-mediated disease
AU2002324193A1 (en) Therapeutic insert and therapeutic method
AU2002243045A1 (en) Pharmaceutical compositiong or preventing and treating cancer and treating an inflammation
AU2001255255A1 (en) Therapeutic compounds and methods
AU2003252397A1 (en) Drugs for preventing and/or treating spinal injury